fangdisun· @fangdisun · X·· 4 天前评分60
正文 · 原文
#ESMO26 starts in less than a week! My summary and comments on notable #HNcancer studies, with several that help contextualize ongoing Ph3 trials in 1L R/M setting. ‼️ None immediately practice-changing in the US, but hope to see more data in the next 1-2 years. @OncBrothers @OncoAlert @myESMO @OncLive
热度 10 · 6 赞 · 0 回复 · 4 转发
会议摘要
NCT04943445NCT04943445按 - **标题 / Title：** Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers 对上
- **标题 / Title：** Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers读摘要原文 →NCT06295731NCT06295731按 - **标题 / Title：** INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC 对上
- **标题 / Title：** INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC读摘要原文 →NCT06385080NCT06385080按 - **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer 对上
- **标题 / Title：** A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer读摘要原文 →NCT06437522NCT06437522按 - **标题 / Title：** A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors 对上
- **标题 / Title：** A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors读摘要原文 →NCT06629597NCT06629597按 - **标题 / Title：** A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) 对上
- **标题 / Title：** A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)读摘要原文 →NCT07276399NCT07276399按 - **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer 对上
- **标题 / Title：** A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer读摘要原文 →来源：fangdisun · x.com